Henry Schein Appoints New Executive Management Committee Members

USA: Henry Schein, a leading solutions company for healthcare professionals, has announced the appointment of three new members to its Executive Management Committee (EMC). Steve Boggan and Bianka Wilson, recently appointed Co-CEOs of the Global Oral Reconstruction Group (GORG), along with Tom Popeck, CEO of the Healthcare Specialties Group (HSG), will join the esteemed committee.

Stanley Bergman, Chairman and CEO of Henry Schein, expressed his enthusiasm for the new appointments, stating, “Steve, Bianka, and Tom have each demonstrated vision and commitment in inspiring and leading our teams to excellence in a quickly changing global healthcare marketplace.”

Strategic Focus

The Global Oral Reconstruction Group (GORG) encompasses a comprehensive portfolio of premium implant lines and biomaterial products, while the Healthcare Specialties Group (HSG) includes various company-owned manufacturing brands in the endodontic, orthodontic, and orthopedic markets. These sectors play a crucial role in advancing Henry Schein’s BOLD+1 strategic plan, aimed at building higher-growth and higher-margin specialty products and services offerings.

Henry Schein Reports Data Breach Affects 29,112 Individuals

Steve Boggan, with a longstanding tenure at Henry Schein since 2013, brings extensive experience from his role as President and CEO of BioHorizons. As Co-CEO of GORG, he will oversee commercial operations and global marketing.

Bianka Wilson, who joined Henry Schein in 2018, brings a wealth of finance and consulting expertise. With her background as Group CFO of Ascom Holding AG and her tenure as Chief Financial Officer of GORG, Wilson will lead strategy, finance, and human resources for the group.

Tom Popeck, who joined Henry Schein in 2019, boasts over two decades of sales leadership and general management experience. His background includes leadership roles in the medical device sector, notably at Stryker, where he held various leadership positions, including Vice President and General Manager of Stryker’s Foot & Ankle business unit.

Company Overview

Henry Schein, Inc. operates as a solutions company for healthcare professionals, providing a wide range of solutions to improve operational success and clinical outcomes. With over 25,000 Team Schein Members worldwide, the company offers more than 300 valued solutions to over 1 million customers globally.

As a FORTUNE 500 Company and a member of the S&P 500 index, Henry Schein’s commitment to innovation and excellence continues to drive its growth and success in the healthcare industry.

For more information, visit Henry Schein at www.henryschein.com.